*💡 What's This About?* A new study published in BMC Cancer examined an innovative combination of two drugs - Pyrotinib and *Etoposide* in metronomic dosing (low continuous dosing) in patients…
What's This About? A new study published in the prestigious The Lancet Oncology examined an innovative drug called Camizestrant in women with hormone-positive (ER+) and HER2-negative metastatic breast cancer, whose…
What happens when a patient with metastatic pancreatic cancer turns to us? Metastatic pancreatic cancer is a particularly challenging disease with a complex prognosis. Standard treatments are primarily based on…
📅 Posted on September 30, 2024 💡 What's This About? A new study examined the combination of two drugs – Eribulin and Carboplatin – in patients with "triple negative" metastatic…
Posted on September 19, 2024 What's This About? 🔍 A promising new study examined the combination of two drugs, Rogaratinib Plus Atezolizumab, in patients with locally advanced or metastatic bladder cancer,…
📅 On September 3, 2024, we received a touching request from a family in Poland, whose young daughter Daria, age 5, was diagnosed with a brain stem tumor after a…
📢 Published on June 13, 2024 Researchers from Stanford University have published the results of a study in Nature Medicine that examined the effectiveness of the treatment combining Botensilimab and…
👉Fate can change in an instant. For Roni, 54 years old, a father and husband, that moment came when he reached out to us. Roni was diagnosed with salivary gland…
We want to share with you the touching story of Michal (a pseudonym), a 32-year-old incredible woman battling metastatic breast cancer, who we have been supporting for some time. Our…
